GlassScriptPhysician profile
Anjali Patel
NPI 1669036869
$2,042.76
in general payments reported to CMS, 2019-2025
18 companies · $995 in 2025
The $995 reported for 2025 was more than what 90% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $445 · 2024: $603 · 2025: $995.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,699 · Travel and Lodging: $344.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,698.80 |
| Travel and Lodging | $343.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $416.75 | 2023-2025 | Aptima |
| Intuitive Surgical, INC. | $343.96 | 2025 | |
| Exeltis, USA INC. | $248.94 | 2023-2025 | Slynd |
| Pfizer INC. | $177.71 | 2024-2025 | |
| Astellas Pharma US INC | $141.87 | 2023 | Veozah |
| Biogen, INC. | $131.54 | 2024-2025 | Zurzuvae |
| Mayne Pharma Commercial LLC | $95.14 | 2024-2025 | |
| Sumitomo Pharma America, INC. | $78.84 | 2024-2025 | Gemtesa, Myfembree |
| Organon LLC | $69.26 | 2024-2025 | Jada System |
| Vertex Pharmaceuticals Incorporated | $64.10 | 2024-2025 | |
| Abbvie INC. | $56.36 | 2023-2025 | |
| Daiichi Sankyo INC. | $54.52 | 2024 | Injectafer |
| Boston Scientific Corporation | $51.29 | 2024 | |
| Coloplast Corp | $32.10 | 2025 | |
| Coopersurgical, INC. | $28.62 | 2025 | Paragard T 380a |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Evofem Biosciences, INC. | $19.39 | 2024 | |
| Shield Therapeutics INC | $17.59 | 2023 | Accrufer |
| Pacira Pharmaceuticals Incorporated | $14.78 | 2025 | Exparel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anjali Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.